Mechanical cardiac assist devices and heart transplantation. Treatment indications and the current situation in Spain;Asistencia mecánica circulatoria y trasplante cardiaco. Indicaciones y situación en España

Revista Espanola de Cardiologia Suplementos

Volumn 6, Issue F, 2006, Pages

  Bueno, Manuel Gómez ^a   Segovia Cubero, Javier ^a   Rivera, Luis Alonso Pulpón ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Advanced heart failure; Cardiac assist devices; Heart transplant

Indexed keywords

AZATHIOPRINE; CALCINEURIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; GANCICLOVIR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR;

ANGIOPLASTY; ARTIFICIAL HEART; ASSISTED CIRCULATION; CARDIAC GRAFT REJECTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONVALESCENCE; COST BENEFIT ANALYSIS; DEFIBRILLATOR; DEVICE; ECHOCARDIOGRAPHY; EMERGENCY SURGERY; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEART GRAFT; HEART SURGERY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE DEFICIENCY; INCIDENCE; INFECTION COMPLICATION; INTRAVASCULAR ULTRASOUND; KAPOSI SARCOMA; KIDNEY FAILURE; NEOPLASM; NEUTROPENIA; POSTOPERATIVE INFECTION; PULSATILE FLOW; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; THROMBOCYTOPATHY; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR DISEASE; VENTILATED PATIENT; CONGESTIVE HEART FAILURE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; SPAIN;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; SPAIN;

EID: 34548672617     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1131-3587(06)74837-3     Document Type: Article

References (52)

1. Mosterd A, Hoes AW, De Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J. 1999;20:447-55.
2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:1116-43
3. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-402.
4. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail. 1999;1:229-41.
5. Goldstein DJ, Oz MC. Cardiac Assist Devices. Armonk: Futura; 2000.
6. Pitsis AA, Dardas P, Mezilis N, Nikoloudakis N, Filippatos G, Burkhoff D. Temporary assist device for postcardiotomy cardiac failure. Ann Thorac Surg. 2004;77:1431-3.
7. Frazier OH, Myers TJ, Westaby S, Gragoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg. 2004;77:133-42.
8. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
9. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, et al, CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-67.
10. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report-2004. J Heart Lung Transplant. 2004;23:1027-34.
11. Stevenson LW, Rose EA. Left ventricular assist devices. Bridges to transplantation, recovery, and destination for whom? Circulation. 2003;108:3059-63.
12. Pavie A, Leger P, Regan M, Szefner J, Nataf P, Bors V, et al. Emergency mechanical circulatory support: still viable? J Heart Lung Transplant. 2000;19:S101-4.
13. Williams MR, Oz MC. Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg. 2001;71 Suppl:S86-91.
14. Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005;112 Suppl:I32-6.
15. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316-22.
16. Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004;110:975-81.
17. Piccione W Jr. Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant. 2000;19:S89-94.
18. Wang SS, Chou NK, Hsu RB, Ko WJ, Yu HY, Chen YS, et al. Heart Transplantation in the patient under ventricular assist complicated with device-related infection. Transplant Proc. 2004;36:2377-9.
19. El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, Inoue K, et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a longterm mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg. 2000;119:581-7.
20. Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant. 2004;23:964-9.
21. Horton SC, Khodaverdian R, Chatelain P, McIntosh ML, Home BD, Muhlestein JB, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45:1435-40.
22. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999;68:2181-4.
23. Ochiai Y, McCarthy PM, Smedira NG, Banbury NK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure alter implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106 Suppl I:I198-202.
24. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report: 2005. J Heart Lung Transplant. 2005;24:945-55.
25. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522-33.
26. Almenar L. Registro Español de Trasplante Cardiaco. XVI Informe Oficial de la Sección de Insuficiencia Cardiaca, Trasplante Cardiaco y Otras Alternativas Terapéuticas de la Sociedad Española de Cardiología. Rev Esp Cardiol. 2005;58:1310-7.
27. Mussivand T. Mechanical circulatory devices for the treatment of heart failure. J Card Surg. 1998;13:218-28.
28. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation. 2005;112:e111-5.
29. Deng MC, Smits JM, Young JB. Proposition: the benefit of cardiac transplantation in stable outpatients with heart failure should be tested in a randomized trial. J Heart Lung Transplant. 2003;22:113-7.
30. Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ. 2000;321:540.
31. Deng MC, Smits JM, De Meester J, Hummel M, Schoendube F, Scheld HH. Heart transplantation indicated only in the most severely ill patient: perspectives from the German heart transplant experience. Curr Opin Cardiol. 2001;16:97-104.
32. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-86.
33. Segovia J, Rodríguez-Lambert JL, Crespo-Leiro MG, Almenar L, Roig E, Gómez-Sánchez MA, et al. Randomized Multicenter Comparison of Basiliximab and Muronomab (OKT3) in Heart Transplantation: SIMCOR Study. Trasplantation. 2006;81:1542-8.
34. Keogh A. Calcineurin inhibitors in heart transplantation. J Heart Lung Transplant. 2004;23:S202-6.
35. Hosenpud JD, Bennett LE. Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS/ISHLT Thoracic Registry. Transplantation. 2001;72:1662-5.
36. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, et al. Drug therapy in the heart transplant recipient. Part II: immunosuppressive drugs. Circulation. 2004;110:3858-65.
37. Keogh A. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. Transplant Proc. 2005;37 Suppl:S1-1.
38. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9:587-93.
39. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710-20.
40. Alonso-Pulpón L, Almenar L, Crespo MG, Silva L, Segovia J, Manito N, et al. Practice guidelines of the Spanish Society of Cardiology. Cardiac and heart-lung transplants. Rev Esp Cardiol. 1999;52:821-39.
41. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, et al; CARGO Investigators. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006;6:150-60.
42. Bernabéu M, Cañas E, Herrero M. Complicaciones infecciosas del trasplante cardiaco. Estudio prospectivo de los seis primeros años de programa de trasplante. Rev Clin Esp. 1999;199:489-95.
43. Documento de consenso GESITRA-SEIMC sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantados. Grupo de Estudio de la Infección en el Trasplante (GESITRA). Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Disponible en: www.seimc.org/gesitra.
44. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant. 2004;23 Suppl:S187-93.
45. Kobashigawa JA. First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation. J Heart Lung Transplant. 2003;22:711-4.
46. Redonnet M, Tron C, Koning R, Bouchart F, Cribier A, Soyer R, et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc. 2000;32:463-5.
47. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, et al. RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349:847-58.
48. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003;108:48-53.
49. Segovia J, Alonso-Pulpón L, Ortiz P, Jiménez-Mazuecos J, Alfonso F, Escaned J, et al. Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. A prospective, randomized intravascular ultrasound study. J Heart Lung Transplant. 2004;23 Suppl:S51-2.
50. Aull MJ, Buell JF, Trofe J, First RM, Alloway RR, Hanaway MJ, et al. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder. Transplantation. 2004;78:1676-82.
51. Briz M, Alonso-Pulpón L, Crespo-Leiro MG, Expósito C, Almagro M, Busto MJ, et al. Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplantation recipients. J Heart Lung Transplant. 1998;17:288-93.
52. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005;35:1317-23.